tiprankstipranks
Trending News
More News >
Astellas Pharma Inc (JP:4503)
:4503
Japanese Market

Astellas Pharma (4503) Ratios

Compare
5 Followers

Astellas Pharma Ratios

JP:4503's free cash flow for Q4 2025 was ¥0.83. For the 2025 fiscal year, JP:4503's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
1.13 0.93 1.45 1.34
Quick Ratio
0.85 0.74 1.21 1.12
Cash Ratio
0.18 0.26 0.52 0.46
Solvency Ratio
0.14 0.09 0.22 0.23
Operating Cash Flow Ratio
0.19 0.13 0.45 0.37
Short-Term Operating Cash Flow Coverage
0.71 0.37 4.37 1.63
Net Current Asset Value
¥ ―¥ -624.94B¥ -778.88B¥ 101.39B¥ 51.27B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.28 0.08 0.09
Debt-to-Equity Ratio
0.62 0.63 0.13 0.15
Debt-to-Capital Ratio
0.38 0.39 0.12 0.13
Long-Term Debt-to-Capital Ratio
0.27 0.22 0.03 0.00
Financial Leverage Ratio
2.21 2.24 1.63 1.60
Debt Service Coverage Ratio
1.60 0.39 2.47 1.28
Interest Coverage Ratio
14.46 19.01 32.51 44.46
Debt to Market Cap
0.33 0.31 0.04 0.04
Interest Debt Per Share
533.33 566.05 114.72 117.69
Net Debt to EBITDA
1.62 3.43 -0.74 -0.43
Profitability Margins
Gross Profit Margin
81.74%81.76%81.01%80.48%
EBIT Margin
13.78%2.31%8.87%12.49%
EBITDA Margin
24.19%12.18%15.83%18.60%
Operating Profit Margin
13.37%11.10%18.80%16.97%
Pretax Profit Margin
1.63%1.56%8.72%12.10%
Net Profit Margin
2.65%1.06%6.50%9.57%
Continuous Operations Profit Margin
2.65%1.06%6.50%9.54%
Net Income Per EBT
162.46%68.26%74.58%79.09%
EBT Per EBIT
12.22%14.02%46.37%71.31%
Return on Assets (ROA)
1.52%0.48%4.02%5.32%
Return on Equity (ROE)
3.35%1.07%6.55%8.50%
Return on Capital Employed (ROCE)
11.22%7.80%16.49%13.38%
Return on Invested Capital (ROIC)
9.98%4.39%11.70%9.56%
Return on Tangible Assets
2.82%1.00%6.31%8.83%
Earnings Yield
1.96%0.58%2.88%3.51%
Efficiency Ratios
Receivables Turnover
2.96 3.00 3.55 3.39
Payables Turnover
4.01 1.58 2.06 1.94
Inventory Turnover
1.17 1.18 1.65 1.65
Fixed Asset Turnover
5.81 5.46 5.30 4.82
Asset Turnover
0.57 0.45 0.62 0.56
Working Capital Turnover Ratio
78.46 13.77 5.42 5.02
Cash Conversion Cycle
343.07 201.06 146.09 139.92
Days of Sales Outstanding
123.34 121.76 102.86 107.70
Days of Inventory Outstanding
310.71 310.41 220.74 220.83
Days of Payables Outstanding
90.97 231.11 177.51 188.61
Operating Cycle
434.05 432.17 323.60 328.53
Cash Flow Ratios
Operating Cash Flow Per Share
112.62 96.18 180.09 139.18
Free Cash Flow Per Share
91.95 50.18 131.44 97.85
CapEx Per Share
20.67 46.00 48.65 41.33
Free Cash Flow to Operating Cash Flow
0.82 0.52 0.73 0.70
Dividend Paid and CapEx Coverage Ratio
1.21 0.87 1.74 1.59
Capital Expenditure Coverage Ratio
5.45 2.09 3.70 3.37
Operating Cash Flow Coverage Ratio
0.22 0.17 1.64 1.21
Operating Cash Flow to Sales Ratio
0.11 0.11 0.22 0.20
Free Cash Flow Yield
6.36%3.06%6.98%5.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
51.03 172.65 34.72 28.49
Price-to-Sales (P/S) Ratio
1.35 1.84 2.26 2.73
Price-to-Book (P/B) Ratio
1.71 1.84 2.27 2.42
Price-to-Free Cash Flow (P/FCF) Ratio
15.73 32.71 14.33 19.53
Price-to-Operating Cash Flow Ratio
12.84 17.06 10.46 13.73
Price-to-Earnings Growth (PEG) Ratio
0.26 -2.09 -1.81 8.60
Price-to-Fair Value
1.71 1.84 2.27 2.42
Enterprise Value Multiple
7.22 18.49 13.52 14.24
Enterprise Value
3.34T 3.61T 3.25T 3.43T
EV to EBITDA
7.22 18.49 13.52 14.24
EV to Sales
1.75 2.25 2.14 2.65
EV to Free Cash Flow
20.28 40.15 13.59 18.96
EV to Operating Cash Flow
16.56 20.95 9.92 13.33
Tangible Book Value Per Share
-14.34 -154.20 339.03 288.61
Shareholders’ Equity Per Share
845.30 889.98 828.54 789.48
Tax and Other Ratios
Effective Tax Rate
-0.62 0.32 0.25 0.21
Revenue Per Share
1.07K 894.27 834.40 700.74
Net Income Per Share
28.35 9.50 54.24 67.08
Tax Burden
1.62 0.68 0.75 0.79
Interest Burden
0.12 0.68 0.98 0.97
Research & Development to Revenue
0.17 0.18 0.18 0.19
SG&A to Revenue
0.00 0.46 0.42 0.42
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00
Income Quality
3.97 10.12 2.48 1.64
Currency in JPY